Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.
The opioid epidemic is likely fueling increased rates of deceased organ donors categorized as posing a high risk of passing on such viruses.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Researchers analyzed 10 biomarkers associated with biological aging among a group of HIV-positive and -negative Europeans.
The U.S. Preventive Services Task Force has reaffirmed its 2009 recommendation.
Cabometyx is the third liver cancer drug approved in the past six months.
More than 3,000 patients have been warned that they may have been exposed to blood-borne pathogens at the facility.
In an analysis of the liver health of a cohort of HIV/hep B–coinfected people, one third had significant fibrosis.
Nearly 3,800 patients at the New Jersey surgery center may have been exposed, though the risk of infection is low.
A closer look at hepatitis B immunization, and what you can do if you aren’t immune after receiving the series of shots.
A light-hearted look at serious issues, such as the rise in hepatitis cases, the opioid epidemic and fatty liver disease.
Here are the treatment news stories on Hep with the most views this year
The FDA’s revision was based on two randomized trials of Viread (tenofovir disoproxil fumarate) use in 2- through 11-year-olds.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.